Tereos Syral plant receives GMP certificate

Following a successful inspection by the Spanish authorities, the Tereos Syral plant in Zaragoza, Spain, has been awarded the good manufacturing practice (GMP) certificate for the manufacture of Meridex pyrogen-free glucose monohydrate as an active pharmaceutical ingredient (API).

The product is fully compliant with the principles of GMP for APIs. The Glucose monohydrate produced in Zaragoza fulfils all of the European and US Pharmacopoeias parameters and also meets the requirements of various applications such as parenteral nutrition, dialysis and injection solutions.

The production unit was specifically designed for lucose monohydrate in September 2011 and uses the most modern technologies known to the field. The first products were supplied to the food sector in January 2013 and then as excipients to the pharmaceutical market in September 2014.